Skip to main content

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 14))

  • 61 Accesses

Abstract

Process validation is a requirement of the Current Good Manufacturing Practices Regulations for Finished Pharmaceuticals (United States) 21 CFR Parts 210 and 211, and of the Good Manufacturing Practice Regulations for Medical Devices, 21 CFR Part 820.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Guideline on general principles of process validation, march 1984 ( FDA, USA).

    Google Scholar 

  2. “FIP-guidelines”. Die Pharmaceutisehe Industrie 1980; 42 Nr. 10.

    Google Scholar 

  3. Sharp J.R . The Pharm Journal, Jan. 11, 1986.

    Google Scholar 

  4. Fry, E. Process validation policy paper presented at Swedish Academy of Pharmaceutical Sciences seminar, April 11 to 13, 1984.

    Google Scholar 

  5. The Gold sheet, Jan. 86.

    Google Scholar 

  6. Agalloco, J.P. Journal of Parenteral Science and Technology 1986; 48: No. 6 nov/dec. 1986.

    Google Scholar 

  7. Loftus and Nash (eds), “Pharmaceutical process validation”, New York: Dekker, 1984.

    Google Scholar 

  8. Fry, Ed ., “Validation theory and concepts”, in collected papers of seminar on Validation, Dublin, June 14–17, 1982, Pharmaceutical Inspection Convention. Geneva: European Free Trade Association, 1982.

    Google Scholar 

  9. Guide to Good Pharmaceutical Manufacturing Practice, 3rd edition, Department of Health, London: HM Stationary Office, 1983.

    Google Scholar 

  10. “Validation of steam sterilisation cycles”, PDA Technical Monograph No. 1. Phi1idelphia, Pa: Parenteral Drug Association, 1978.

    Google Scholar 

  11. “Validation of aseptic filling for solution drug products”, PDA Technical Monograph No 2, Phi1idelphia, Pa: Parenteral Drug Association, 1980.

    Google Scholar 

  12. Validation of dry heat processes used for sterilisation and depyrogenisation”. PDA Technical Report No 3, Philadelphia, Pa: Parenteral Drug Association, 1981.

    Google Scholar 

  13. “Validation”. PIC seminar june 1982, EFTA secretariat, Geneva, 1982.

    Google Scholar 

  14. Sucker, M. Praxis der Valiedierung. APV seminar. Wissenschaftliche Verlagsgeselschaft GmbH, Stuttgart, 1982.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Bachmann, E. (1987). Process Validation. In: Kristensen, K., Nørbygaard, E. (eds) Safety and Efficacy of Radiopharmaceuticals 1987. Developments in Nuclear Medicine, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3375-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3375-0_29

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8016-3

  • Online ISBN: 978-94-009-3375-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics